ATE163404T1 - Anthracen derivate zur verwendung als anti- krebsmittel oder farbstoff - Google Patents

Anthracen derivate zur verwendung als anti- krebsmittel oder farbstoff

Info

Publication number
ATE163404T1
ATE163404T1 AT94927754T AT94927754T ATE163404T1 AT E163404 T1 ATE163404 T1 AT E163404T1 AT 94927754 T AT94927754 T AT 94927754T AT 94927754 T AT94927754 T AT 94927754T AT E163404 T1 ATE163404 T1 AT E163404T1
Authority
AT
Austria
Prior art keywords
pct
group
hydrogen
dye
sec
Prior art date
Application number
AT94927754T
Other languages
English (en)
Inventor
David John Mincher
Original Assignee
Univ Napier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Napier filed Critical Univ Napier
Application granted granted Critical
Publication of ATE163404T1 publication Critical patent/ATE163404T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/24—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings
    • C07C225/26—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings
    • C07C225/32—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings of condensed quinone ring systems formed by at least three rings
    • C07C225/34—Amino anthraquinones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/10—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/24—Anthracenes; Hydrogenated anthracenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94927754T 1993-09-30 1994-09-30 Anthracen derivate zur verwendung als anti- krebsmittel oder farbstoff ATE163404T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939320191A GB9320191D0 (en) 1993-09-30 1993-09-30 Compounds

Publications (1)

Publication Number Publication Date
ATE163404T1 true ATE163404T1 (de) 1998-03-15

Family

ID=10742784

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94927754T ATE163404T1 (de) 1993-09-30 1994-09-30 Anthracen derivate zur verwendung als anti- krebsmittel oder farbstoff

Country Status (10)

Country Link
US (1) US5733880A (de)
EP (1) EP0721447B1 (de)
JP (1) JPH09506862A (de)
AT (1) ATE163404T1 (de)
AU (1) AU7705294A (de)
CA (1) CA2172958A1 (de)
DE (1) DE69408683T2 (de)
ES (1) ES2115977T3 (de)
GB (1) GB9320191D0 (de)
WO (1) WO1995009149A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143864A (en) * 1994-06-28 2000-11-07 Merck & Co., Inc. Peptides
GB9812937D0 (en) * 1998-06-16 1998-08-12 Btg Int Ltd Compounds
FR2786484B1 (fr) * 1998-11-30 2001-01-05 Oreal Aminoanthraquinones cationiques, leur utilisation pour la teinture des fibres keratiniques, compositions tinctoriales les renfermant et procedes de teinture
GB9903548D0 (en) * 1999-02-16 1999-04-07 Novartis Ag Organic compounds
GB9929801D0 (en) * 1999-12-16 2000-02-09 Btg Int Ltd Anti-cancer agents iii
US6306435B1 (en) 2000-06-26 2001-10-23 Yung Shin Pharmaceutical Industrial Co. Ltd. Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
US6800615B2 (en) * 2002-04-15 2004-10-05 Board Of Trustees Of Michigan State University Antihelminthic anthraquinones and method of use thereof
US20060099712A1 (en) * 2004-11-08 2006-05-11 Eastman Kodak Company Correlation of anti-cancer activity of dyes with redox potentials
EP1905801A1 (de) * 2006-09-27 2008-04-02 Universität Heidelberg Nah-infrarot Fluorophore zur selektiven Markierung von Membranzellen
US8790892B2 (en) * 2011-04-04 2014-07-29 Biotium, Inc. Substituted anthraquinone dyes for cellular stains and enzyme detection
US9040567B2 (en) 2011-08-19 2015-05-26 Emory University BAX agonist, compositions, and methods related thereto
EP3140275B1 (de) 2014-05-05 2020-07-08 Emory University Kombination eines bh4 antagonisten und eines mtor inhibitors zur lungenkrebstherapie
KR102100729B1 (ko) * 2018-10-30 2020-04-14 계명대학교 산학협력단 안트라퀴논계 화합물 및 이를 유효성분으로 함유하는 암질환 예방 또는 치료용 조성물
JP2024515964A (ja) * 2021-04-26 2024-04-11 オハイオ ステート イノベーション ファウンデーション 脂質ナノ材料及びその使用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57141456A (en) * 1981-02-27 1982-09-01 Toyo Ink Mfg Co Ltd Pigment composition
US4894451A (en) * 1985-04-01 1990-01-16 The University Of Vermont Unsymmetrical 1,4-bis(aminoalkylamino)-anthracene-9, 10-diones and derivatives
US4732970A (en) * 1986-06-13 1988-03-22 American Cyanamid Company Antitumor amino acid and peptide derivatives of 1,4-bis(aminoalkyl and hydroxy-aminoalkyl)amino)-5,8-dihydroxyanthraquinones
US4847359A (en) * 1986-06-30 1989-07-11 Ciba-Geigy Corporation Diamino-9,10-dihydroanthracenes and polyamide acid (esters) and polyimides derived therefrom
DE3862347D1 (de) * 1987-07-01 1991-05-16 Ciba Geigy Ag Substituierte anthrachinone und haertbare zusammensetzung.
GB8715436D0 (en) * 1987-07-01 1987-08-05 Ciba Geigy Ag Substituted anthraquinones
US4855084A (en) * 1987-07-01 1989-08-08 Ciba-Geigy Corporation Anthraquinoylcarboxylic acid hydrazides, curable compositions and use thereof
DE4032607A1 (de) * 1990-10-15 1992-05-07 Wella Ag Mittel zum faerben von haaren mit einem gehalt an 1,4-bis((dihydroxyalkyl)amino)-anthrachinon sowie neue 1,4-bis-((dihydroxyalkyl)amino)- anthrachinone
CA2072889A1 (en) * 1990-11-02 1992-05-03 Jack B. Jiang Bis-(hydroxyalkylamino)-anthraquinone inhibitors of protein kinase c
EP0489220A1 (de) * 1990-12-02 1992-06-10 American Cyanamid Company Cytotoxische N,N'-bis (succinyl-peptid)-Derivate von 1,4-bis (aminoalkyl)-5,8-dihydroxyanthrachinonen und Antikörperkonjugate davon
GB9205859D0 (en) * 1992-03-18 1992-04-29 Imp Cancer Res Tech Compounds

Also Published As

Publication number Publication date
DE69408683T2 (de) 1998-10-01
JPH09506862A (ja) 1997-07-08
AU7705294A (en) 1995-04-18
EP0721447A1 (de) 1996-07-17
GB9320191D0 (en) 1993-11-17
ES2115977T3 (es) 1998-07-01
DE69408683D1 (de) 1998-04-02
CA2172958A1 (en) 1995-04-06
EP0721447B1 (de) 1998-02-25
US5733880A (en) 1998-03-31
WO1995009149A1 (en) 1995-04-06

Similar Documents

Publication Publication Date Title
DE69408683D1 (de) Anthracen derivate zur verwendung als anti-krebsmittel oder farbstoff
ATE36699T1 (de) Chinonderivate, verfahren zu ihrer herstellung, ihre verwendung und pharmazeutische zusammensetzung.
TR199901578T2 (xx) Klaritromisin form 0 kristali
FI932229A0 (fi) Azabicykliska bryggderivat
TR200102800T2 (tr) Yeni bileşikler.
DE59103595D1 (de) Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel.
MX9701538A (es) Sales de un derivado del indol contra la migraña.
ATE158588T1 (de) Peptide mit eine alphaaminoboronaire gruppe and ihre verwendung als elastasehemmer
AU6539590A (en) (diethylamino-N-oxide) ethylamino-dihydroxyanthracene-9, 10-dione derivatives
TR199900501T2 (xx) Benzamin t�revleri ve bunlar�n ila� olarak kullan�m�.
PT91211A (pt) Processo para a preparacao de compostos poliaza macrociclicos contendo aneis de 5 ou 6 membros, e de composicoes farmaceuticas que os contem
ATE73790T1 (de) Amino 5,6,7,8tetrahydronaphtho(2,3b>furanderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ZA945007B (en) Heterocyclic derivatives
CA2196900A1 (en) Fluorinated 2-nitroimidazole analogs for detecting hypoxic tumor cells
ES8403910A1 (es) Procedimiento para la preparacion de nitratos de amino-deso-xi-1.4;3.6-dianhidro-hexito,asi como de sus sales de adicionacida farmacologicamente inocuas
PE84299A1 (es) Compuestos policiclicos parcialmente hidrogenados
ATE50448T1 (de) 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-o - verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ATE154031T1 (de) 8-en-19, 11 beta-überbrückte steroide, deren herstellung und diese enthaltende pharmazeutische präparate
ATE15047T1 (de) Galactopyranoside verbindungen, verfahren zu ihrer herstellung und ihre verwendung als antigene oder immunadsorbentien.
IL111725A0 (en) 3'-aziridino-anthracycline derivatives, their preparation and pharmaceutical compositions containing them
ATE63117T1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
ATE35683T1 (de) Photopolymerisierbares gemisch, das als photoinitiator ein 1,3,10-triazaanthracen-4-on enthaelt.
ATE273948T1 (de) Anthracene derivative als antitumormittel
PT77683B (de) Neue benzazepinderivate ihre herstellung und ihre verwendung als arzneimittel
ATE4720T1 (de) Neue derivate von cardenolid-bis-digitoxosiden, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee